US Stock MarketDetailed Quotes

LUMO Lumos Pharma

Watchlist
  • 2.760
  • 0.0000.00%
Trading Apr 25 15:58 ET
22.40MMarket Cap-660P/E (TTM)

Lumos Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
34.67%2.05M
61.33%826K
-98.59%7K
136.96%1.22M
522.52%691K
562.17%1.52M
132.73%512K
497K
5,040.00%514K
111K
Operating revenue
34.67%2.05M
61.33%826K
-98.59%7K
136.96%1.22M
522.52%691K
562.17%1.52M
132.73%512K
--497K
5,040.00%514K
--111K
Cost of revenue
Gross profit
Operating expense
15.20%38.67M
15.87%10.83M
11.08%8.94M
16.87%18.9M
11.27%8.73M
6.29%33.56M
37.68%9.35M
7.34%8.05M
86.41%16.17M
-8.99%7.84M
Selling and administrative expenses
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
16.43%8.5M
20.33%4.36M
2.45%15.71M
30.83%4.49M
15.75%3.92M
60.12%7.3M
-8.49%3.62M
-General and administrative expense
5.49%16.57M
-6.96%4.17M
-0.64%3.89M
16.43%8.5M
20.33%4.36M
2.45%15.71M
30.83%4.49M
15.75%3.92M
60.12%7.3M
-8.49%3.62M
Research and development costs
23.74%22.1M
36.92%6.66M
22.21%5.05M
17.22%10.39M
3.51%4.37M
9.92%17.86M
44.66%4.86M
0.41%4.13M
115.56%8.87M
-9.42%4.22M
Operating profit
-14.28%-36.61M
-13.23%-10M
-18.30%-8.93M
-12.92%-17.68M
-3.93%-8.04M
-2.21%-32.04M
-34.50%-8.84M
-0.71%-7.55M
-80.69%-15.66M
10.28%-7.73M
Net non-operating interest income expense
113.73%1.87M
-41.75%293K
52.74%446K
1,329.11%1.13M
11,300.00%570K
7,183.33%874K
1,097.62%503K
14,500.00%292K
3,850.00%79K
114.71%5K
Non-operating interest income
113.73%1.87M
-41.75%293K
52.74%446K
1,329.11%1.13M
11,300.00%570K
7,183.33%874K
9,960.00%503K
14,500.00%292K
3,850.00%79K
66.67%5K
Other net income (expense)
650.55%683K
252.78%254K
2,557.14%186K
1,925.00%243K
1,883.33%119K
-66.17%91K
-71.20%72K
0.00%7K
250.00%12K
-70.00%6K
Other non- operating income (expenses)
650.55%683K
252.78%254K
2,557.14%186K
1,925.00%243K
1,883.33%119K
-66.17%91K
-71.20%72K
0.00%7K
250.00%12K
-70.00%6K
Income before tax
-9.62%-34.06M
-14.49%-9.46M
-14.47%-8.3M
-4.77%-16.31M
4.84%-7.35M
-0.03%-31.08M
-31.59%-8.26M
3.17%-7.25M
-79.52%-15.56M
10.55%-7.72M
Income tax
-123.08%-29K
0
0
-29K
97.96%-13K
-13K
0
0
Net income
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
10.55%-7.72M
Net income continuous Operations
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
10.55%-7.72M
Minority interest income
Net income attributable to the parent company
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
10.55%-7.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-9.57%-34.03M
-14.67%-9.46M
-14.47%-8.3M
-4.58%-16.28M
4.84%-7.35M
-2.08%-31.06M
-46.20%-8.25M
3.17%-7.25M
-79.52%-15.56M
10.55%-7.72M
Basic earnings per share
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
-6.45%-1.98
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
4.44%-0.86
-87.88%-1.86
11.54%-0.92
Diluted earnings per share
-12.67%-4.18
-19.39%-1.17
-20.93%-1.04
-6.45%-1.98
3.26%-0.89
-1.64%-3.71
-44.12%-0.98
4.44%-0.86
-87.88%-1.86
11.54%-0.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 34.67%2.05M61.33%826K-98.59%7K136.96%1.22M522.52%691K562.17%1.52M132.73%512K497K5,040.00%514K111K
Operating revenue 34.67%2.05M61.33%826K-98.59%7K136.96%1.22M522.52%691K562.17%1.52M132.73%512K--497K5,040.00%514K--111K
Cost of revenue
Gross profit
Operating expense 15.20%38.67M15.87%10.83M11.08%8.94M16.87%18.9M11.27%8.73M6.29%33.56M37.68%9.35M7.34%8.05M86.41%16.17M-8.99%7.84M
Selling and administrative expenses 5.49%16.57M-6.96%4.17M-0.64%3.89M16.43%8.5M20.33%4.36M2.45%15.71M30.83%4.49M15.75%3.92M60.12%7.3M-8.49%3.62M
-General and administrative expense 5.49%16.57M-6.96%4.17M-0.64%3.89M16.43%8.5M20.33%4.36M2.45%15.71M30.83%4.49M15.75%3.92M60.12%7.3M-8.49%3.62M
Research and development costs 23.74%22.1M36.92%6.66M22.21%5.05M17.22%10.39M3.51%4.37M9.92%17.86M44.66%4.86M0.41%4.13M115.56%8.87M-9.42%4.22M
Operating profit -14.28%-36.61M-13.23%-10M-18.30%-8.93M-12.92%-17.68M-3.93%-8.04M-2.21%-32.04M-34.50%-8.84M-0.71%-7.55M-80.69%-15.66M10.28%-7.73M
Net non-operating interest income expense 113.73%1.87M-41.75%293K52.74%446K1,329.11%1.13M11,300.00%570K7,183.33%874K1,097.62%503K14,500.00%292K3,850.00%79K114.71%5K
Non-operating interest income 113.73%1.87M-41.75%293K52.74%446K1,329.11%1.13M11,300.00%570K7,183.33%874K9,960.00%503K14,500.00%292K3,850.00%79K66.67%5K
Other net income (expense) 650.55%683K252.78%254K2,557.14%186K1,925.00%243K1,883.33%119K-66.17%91K-71.20%72K0.00%7K250.00%12K-70.00%6K
Other non- operating income (expenses) 650.55%683K252.78%254K2,557.14%186K1,925.00%243K1,883.33%119K-66.17%91K-71.20%72K0.00%7K250.00%12K-70.00%6K
Income before tax -9.62%-34.06M-14.49%-9.46M-14.47%-8.3M-4.77%-16.31M4.84%-7.35M-0.03%-31.08M-31.59%-8.26M3.17%-7.25M-79.52%-15.56M10.55%-7.72M
Income tax -123.08%-29K00-29K97.96%-13K-13K00
Net income -9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M10.55%-7.72M
Net income continuous Operations -9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M10.55%-7.72M
Minority interest income
Net income attributable to the parent company -9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M10.55%-7.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -9.57%-34.03M-14.67%-9.46M-14.47%-8.3M-4.58%-16.28M4.84%-7.35M-2.08%-31.06M-46.20%-8.25M3.17%-7.25M-79.52%-15.56M10.55%-7.72M
Basic earnings per share -12.67%-4.18-19.39%-1.17-20.93%-1.04-6.45%-1.983.26%-0.89-1.64%-3.71-44.12%-0.984.44%-0.86-87.88%-1.8611.54%-0.92
Diluted earnings per share -12.67%-4.18-19.39%-1.17-20.93%-1.04-6.45%-1.983.26%-0.89-1.64%-3.71-44.12%-0.984.44%-0.86-87.88%-1.8611.54%-0.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg